Latest news

U.K. startup Fluent has closed a $7.5 million seed investment round led by Hoxton Ventures

UK biotech Baseimmune raises £9m to develop ‘mutation-proof’ vaccines

An ‘outsider’ in European VC, Midas newcomer Hussein Kanji wants to bring Silicon Valley to Europe

Hoxton Ventures ranked 8th best venture firm globally in 2023

Hoxton Ventures shoots for the big time, luring Bryan Gartner from Khosla Ventures

Preply raised $70 million Series C

DRUID raises $30m to double down on US business

KITT office space designer and manager raises $8M from Hoxton Ventures

From photography to no code data analytics, Graphext raises $4.6 million

Duo make room for AI to crack £700bn homewares market

BioCorteX Raises $5 Million in Funding Led by Sofinnova Partners and Hoxton Ventures To Unlock Drug-Bacteria Interactions

Revolut and Ledger alumni quietly raise €12m for new crypto startup Deblock

Inflow ADHD app nets £9m investment boost

MultiOmic Health Closes $6.2 Million Funding Round to Discover Precision Medicines for Metabolic Syndrome-Related Conditions

VCs need to return cash to their investors. The secondary market is coming alive as a result.

Pear Bio adds $14 million to its coffers

Using A.I. to Detect Breast Cancer That Doctors Miss

Hide and Really Clever [Business Insider] were both profiled as some of the most interesting startups in sustainability

Hoxton sees bridge to US investors as key to becoming top European VC